- Case report
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Abscess of adrenal gland caused by disseminated subacute Nocardia farcinica pneumonia. A case report and mini-review of the literature
© Tachezy et al; licensee BioMed Central Ltd. 2009
Received: 18 March 2009
Accepted: 2 December 2009
Published: 2 December 2009
Infections caused by Nocardia farcinica are uncommon and show a great variety of clinical manifestations in immunocompetent and immunocompromised patients. Because of its unspecific symptoms and tendency to disseminate it may mimic the clinical symptoms and radiologic findings of a tumour disease and the diagnosis of nocardiosis can easily be missed, because there are no characteristic symptoms.
We present a case of an adrenal gland abscess caused by subacute disseminated N. farcinica pneumonia.
An infection with N. farcinica is potentially lethal because of its tendency to disseminate -particularly in the brain- and its high resistance to antibiotics. Awareness of this differential diagnosis allows early and appropriate treatment to be administered.
Nocardia species are aerobic, gram positive, filamentous, weakly acid-fast bacteria which grow worldwide in soils as well as animal tissues. There are more than eighty N. species described until now , thereof one-half are recognized as pathogens in humans or animals [2, 3]. In recent years because of the use of molecular techniques the taxonomy of Nocardia has been revised extensively [2–5].
An infection with N. farcinica is potentially lethal because of its tendency to disseminate and its resistance to antibiotics [6–9]. N. farcinica is one of the prevalent species causing nocardiosis .
Definite rates of pulmonary N. farcinica infections are not known, but might not be as rare as generally assumed. Some reports indicate an increasing incidence because of a higher rate of immunodeficient patients, as well as improved techniques to identify the bacteria .
Most of the symptomatic patients with pulmonary nocardiosis have a predisposing immunocomprimising disease such as malignancies, advanced HIV infection, diabetes mellitus, renal dysfunction, collagen vascular diseases, alcoholism, tuberculosis, preceding operations, chronic obstructive pulmonary disease (COPD), trauma or abnormal phagocytic activity and medical immunosupression e.g. steroid therapy . In 15% of the cases it occurs without underlying illness [6, 12].
The patient presented in this case had no obvious immunodeficiency. Possibly the combination of an alcoholic toxicomania in the past (without any signs of liver disease) and the decreased general condition and nutritional status have made the patient susceptible for the infection.
Nocardiosis is usually acquired through the lung, but also by inoculation through traumatic injury of the integument [6, 13, 15]. Although health care-associated transmission has been documented, human-to-human transmission of nocardiosis is considered to be improbable [2, 3, 16]. It possibly metastasizes hematogenously into distant organs, especially the brain, followed by kidney, joints, bones and eyes [6, 17]. Involvement of other organs like adrenal gland is less common [18–21].
Nocardiosis is a microbiological diagnosis. N. farcinica can be isolated in clinical specimen like pus, sputum, bronchial secretion, biopsies, blood and urine in many culture media after two to 14 days . Because of the potentially long culture time it is very important, that the physicians notify the laboratory when Nocardia is suspected in a clinical specimen. One of the most important findings is the presentation of the typical morphology of N. species surrounded by acute inflammatory cells on a direct Gram-stained smear . Determination of the identification of the N. species via biochemical and/or molecular methods (which is the most reliable method for identification) and of course the antimicrobial susceptibility profile is important for the treatment of the patient .
When pulmonary nocardiosis is diagnosed, a CT or MRT of the brain and abdomen should be considered.
Therapy of the disease depends -beside the species and its antibiogram- on the severity of the infection, if and where it disseminated and the immune status of the patient.
The empiric gold standard of medical treatment is trimethoprim-sulfamethoxazole (TMP-SMX), which well penetrates the cerebral barrier , but N. farcinica has a high rate of resistance against TMP-SMX [6–9].
Amikacin, imipenem, third generation cephalosporins, minocycline, netilmicin and amoxicillin-clavulanic acid are second line antibiotics for nocardiosis . There is a characteristic resistance of N. farcinica to ampicillin, broad-spectrum cephalosporine, clarithromycin and aminoglycosides except amikacin. It is susceptible to ciprofloxacin, linezolid and imipenem .
Patients with disseminated disease, especially the CNS, should be treated with a combined therapy including TMP-SMX and a bactericidal agent or a combination of imipenem and amikacin. Involvement of CNS might be treated with third generation cephalosporins . Further medical treatment would be based on susceptibility results. Therapy must start intravenously and can later be replaced by oral therapy depending on clinical and radiological responses. An alternative antibiotic drug for resistant bacteria is linezolid .
The therapy has to be continued for several months because of high relapse rates, depending on the immune status of the patient. If CNS is involved, therapy must last at least 12 months [14, 25], followed by monitoring for at least another year after completion of the therapy . Patients with a persisting immunodeficiency should receive a prolonged therapy and a low-dose prophylaxis .
In addition to drug treatment a larger abdominal abscess should be treated by drainage and/or radical excision. Cerebral abscesses can be excised and this seems to lower the mortality of the patient compared to solitary drug treatment with or without aspiration/drainage, depending on the size and growing behaviour over time .
Data about the prognosis are highly oscillating, mortality rates between 14% and 40% have been published, in case of dissemination even 100% . Depending on the point of diagnosis, the beginning of the treatment and the resistance to antibiotics, as well as secondary host factors, the mortality rate of cerebral abscesses may even be higher, 75% to 90% [29, 30].
This case report presents the surprising diagnosis of an adrenal abscess caused by Nocardia farcinica mimicking a malignant adrenal mass and nicely demonstrates that pulmonary Nocardia infections can easily be misdiagnosed, because in the beginning there are only uncharacteristic symptoms of acute, subacute or chronic pneumonia. Furthermore, the case illustrates the difficulty to differentiate between adrenal abscess, adrenal metastasis, necrotic malignant tumour and complex adrenal cysts on CT , although contrast CT is generally accepted as the cornerstone of adrenal imaging .
Initial reason for hospitalization of the 71 year old female patient in the department of internal medicine was an atypical pneumonia with the symptoms of low-grade fever and a cough without expectoration in combination with a progredient adynamia, a reduced general condition (40%, Karnofsky performance status scale), subtle nausea and a lowered ability to concentrate in the last four weeks. Relevant ancillary diagnoses were arterial hypertension, cardiac insufficiency (NYHA II) and former alcohol addiction without any evidence for a liver disease. Home medication was an antihypertensive combination therapy (Bisoprolol 5 mg and Hydrochlorothiazid/Ramipril 12.5/5 mg).
Physical examination of the underweight patient (47 kg/168 cm) revealed basal crackles on both lungs and low fever (37.8°C). Neurologic status was without pathologic findings.
A diagnosis of atypical pneumonia was established and an empiric antibiotic treatment with gentamicin and ceftriaxone was initiated. Under therapy febrile temperature and abnormal laboratory values decreased in the following days (Leucocytes 12.1/nl and CrP 7.3 mg/dl).
Initial examination included an abdominal ultrasound, which showed a suspicious right-sided retrohepatic, suprarenal incidentaloma.
Furthermore, CT supported the diagnosis atypical pneumonia with parenchymal infiltrations in the whole lung and partial nodular changes of the parenchyma with reactive effusion. It showed enlarged bronchopulmonary, hilar and mediastinal lymph nodes, which were interpreted as pneumonic inflammatory effects.
Because of the diagnosis of a malignant tumour the patient was transferred to our surgical clinic after recovering from pneumonia. At that time leucocytes and CrP had nearly decreased to a physiologic level (10.4/nl and 2.83 mg/l).
To exclude an endocrine activity of the tumour, levels of suprarenal hormones were determined in plasma and urine, respectively (Metanephrine- and aldosterone-levels in collected urine and dexamethasone suppression tests were at a physiologic level).
We performed a radical in toto resection of the right adrenal gland. The intraoperative finding showed a dense adrenal mass infiltrating the surrounding tissues so that a tangential resection of the Vena cava inferior, diaphragm, retroperitoneum and Gerota's fascia was performed. The specimen was sent for pathological analysis.
A routine chest x-ray in the ICU one day after the operation showed recurrent pneumonic infiltrations. Endotracheal aspirates were purulent and the material was sent for microbiological analysis. An antibiotic treatment was started with piperacillin/sulbactam.
Histology of the adrenal gland revealed a necrotic and chronic putrid abscess-formation (Figure 3B).
An aspiration or drainage was discussed, but because of the size and multiplicity of cerebral abscesses neurosurgeons favoured a non-invasive therapy.
We administered an intravenous antibiotic therapy with imipenem/cilastatin and amikacin for three weeks and later according to the susceptibility results we added trimethoprim-sulfamethoxazole (TMP-SMX) (good susceptibility of TMP-SMX, imipenem, meropenem and amikacin). Intravenous therapy was continued for six weeks and after discharge an oral trimethoprim-sulfamethoxazole therapy was administered for another twelve months.
Under pharmaceutical therapy and physiotherapy the neurological status improved and the patient was transferred to a neurologic rehabilitation three weeks after the operation.
In a follow-up cranial MRI six month later, the previously detected foci had become smaller or had completely disappeared.
Because of its low incidence nocardia infections are not well known and are therefore very often not considered in the initial diagnosis.
We recommend keeping nocardia infection in mind for patients with atypical pneumonia unresponsive to empirical broad-spectrum antibiosis even in previously healthy patients, even more so if they have any suspicious tumour and/or neurologic symptoms.
Delay of adequate antibiotic therapy can have serious consequences.
Furthermore, this case shows the necessity to keep the possibility of an adrenal abscess in mind as one of the differential diagnosis for adrenal incidentaloma in the presence of such clinical and diagnostical findings.
- Euzèby J: List of bacterial names with standing in nomenclature - Genus Nocardia. 2009, [http://www.bacterio.cict.fr/n/nocardia.html]Google Scholar
- Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ: Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006, 19 (2): 259-282. 10.1128/CMR.19.2.259-282.2006.View ArticlePubMedPubMed CentralGoogle Scholar
- Martinez R, Reyes S, Menendez R: Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis. Curr Opin Pulm Med. 2008, 14 (3): 219-227. 10.1097/MCP.0b013e3282f85dd3.View ArticlePubMedGoogle Scholar
- Roth A, Andrees S, Kroppenstedt RM, Harmsen D, Mauch H: Phylogeny of the genus Nocardia based on reassessed 16S rRNA gene sequences reveals underspeciation and division of strains classified as Nocardia asteroides into three established species and two unnamed taxons. J Clin Microbiol. 2003, 41 (2): 851-856. 10.1128/JCM.41.2.851-856.2003.View ArticlePubMedPubMed CentralGoogle Scholar
- Cloud JL, Conville PS, Croft A, Harmsen D, Witebsky FG, Carroll KC: Evaluation of partial 16S ribosomal DNA sequencing for identification of nocardia species by using the MicroSeq 500 system with an expanded database. J Clin Microbiol. 2004, 42 (2): 578-584. 10.1128/JCM.42.2.578-584.2004.View ArticlePubMedPubMed CentralGoogle Scholar
- Torres OH, Domingo P, Pericas R, Boiron P, Montiel JA, Vazquez G: Infection caused by Nocardia farcinica: case report and review. Eur J Clin Microbiol Infect Dis. 2000, 19 (3): 205-212. 10.1007/s100960050460.View ArticlePubMedGoogle Scholar
- Munoz J, Mirelis B, Aragon LM, Gutierrez N, Sanchez F, Espanol M, Esparcia O, Gurgui M, Domingo P, Coll P: Clinical and microbiological features of nocardiosis 1997-2003. J Med Microbiol. 2007, 56 (Pt 4): 545-550. 10.1099/jmm.0.46774-0.View ArticlePubMedGoogle Scholar
- Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, Shutt KA, Kwak EJ, Paterson DL: Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis. 2007, 44 (10): 1307-1314. 10.1086/514340.View ArticlePubMedGoogle Scholar
- Hitti W, Wolff M: Two cases of multidrug-resistant Nocardia farcinica infection in immunosuppressed patients and implications for empiric therapy. Eur J Clin Microbiol Infect Dis. 2005, 24 (2): 142-144. 10.1007/s10096-005-1285-y.View ArticlePubMedGoogle Scholar
- Rivero A, Garcia-Lazaro M, Perez-Camacho I, Natera C, del Carmen Almodovar M, Camacho A, Torre-Cisneros J: Successful long-term treatment with linezolid for disseminated infection with multiresistant Nocardia farcinica. Infection. 2008, 36 (4): 389-391. 10.1007/s15010-008-7236-7.View ArticlePubMedGoogle Scholar
- De La Iglesia P, Viejo G, Gomez B, De Miguel D, Del Valle A, Otero L: Fatal pulmonary Nocardia farcinica infection. J Clin Microbiol. 2002, 40 (3): 1098-1099. 10.1128/JCM.40.3.1098-1099.2002.View ArticlePubMedPubMed CentralGoogle Scholar
- Kageyama A, Yazawa K, Ishikawa J, Hotta K, Nishimura K, Mikami Y: Nocardial infections in Japan from 1992 to including the first report of infection by Nocardia transvalensis. Eur J Epidemiol. 2001, 19 (4): 383-389. 10.1023/B:EJEP.0000024706.02325.c0.View ArticleGoogle Scholar
- Boiron P, Provost F, Chevrier G, Dupont B: Review of nocardial infections in France 1987 to 1990. Eur J Clin Microbiol Infect Dis. 1992, 11 (8): 709-714. 10.1007/BF01989975.View ArticlePubMedGoogle Scholar
- Lerner PI: Nocardiosis. Clin Infect Dis. 1996, 22 (6): 891-903.View ArticlePubMedGoogle Scholar
- Beaman BL, Beaman L: Nocardia species: host-parasite relationships. Clin Microbiol Rev. 1994, 7 (2): 213-264.View ArticlePubMedPubMed CentralGoogle Scholar
- Houang ET, Lovett IS, Thompson FD, Harrison AR, Joekes AM, Goodfellow M: Nocardia asteroides infection--a transmissible disease. J Hosp Infect. 1980, 1 (1): 31-40. 10.1016/0195-6701(80)90029-8.View ArticlePubMedGoogle Scholar
- Braun TI, Kerson LA, Eisenberg FP: Nocardial brain abscesses in a pregnant woman. Rev Infect Dis. 1991, 13 (4): 630-632.View ArticlePubMedGoogle Scholar
- Chong YL, Tan JK, Teo N: Clinics in diagnostic imaging (109). Nocardial adrenal abscess. Singapore Med J. 2006, 47 (5): 425-429.PubMedGoogle Scholar
- Midiri M, Finazzo M, Bartolotta TV, Maria MD: Nocardial adrenal abscess: CT and MR findings. Eur Radiol. 1998, 8 (3): 466-468. 10.1007/s003300050415.View ArticlePubMedGoogle Scholar
- Al-Tawfiq JA, Al-Khatti AA: Disseminated systemic Nocardia farcinica infection complicating alefacept and infliximab therapy in a patient with severe psoriasis. Int J Infect Dis. 2009Google Scholar
- Arabi Y, Fairfax MR, Szuba MJ, Crane L, Schuman P: Adrenal insufficiency, recurrent bacteremia, and disseminated abscesses caused by Nocardia asteroides in a patient with acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis. 1996, 24 (1): 47-51. 10.1016/0732-8893(95)00249-9.View ArticlePubMedGoogle Scholar
- Sabuncuoglu H, Cibali Acikgo ZZ, Caydere M, Ustun H, Semih Keskil I: Nocardia farcinica brain abscess: a case report and review of the literature. Neurocirugia (Astur). 2004, 15 (6): 600-603.View ArticleGoogle Scholar
- Glupczynski Y, Berhin C, Janssens M, Wauters G: Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin Microbiol Infect. 2006, 12 (9): 905-912. 10.1111/j.1469-0691.2006.01460.x.View ArticlePubMedGoogle Scholar
- Byrne E, Brophy BP, Perrett LV: Nocardia cerebral abscess: New concepts in diagnosis, management, and prognosis. J Neurol Neurosurg Psychiatry. 1979, 42 (11): 1038-1045. 10.1136/jnnp.42.11.1038.View ArticlePubMedPubMed CentralGoogle Scholar
- Kramer MR, Uttamchandani RB: The radiographic appearance of pulmonary nocardiosis associated with AIDS. Chest. 1990, 98 (2): 382-385. 10.1378/chest.98.2.382.View ArticlePubMedGoogle Scholar
- Geiseler PJ, Andersen BR: Results of therapy in systemic nocardiosis. Am J Med Sci. 1979, 278 (3): 188-194. 10.1097/00000441-197911000-00001.View ArticlePubMedGoogle Scholar
- Smego RA, Moeller MB, Gallis HA: Trimethoprim-sulfamethoxazole therapy for Nocardia infections. Arch Intern Med. 1983, 143 (4): 711-718. 10.1001/archinte.143.4.711.View ArticlePubMedGoogle Scholar
- Mamelak AN, Obana WG, Flaherty JF, Rosenblum ML: Nocardial brain abscess: treatment strategies and factors influencing outcome. Neurosurgery. 1994, 35 (4): 622-631. 10.1097/00006123-199410000-00007.View ArticlePubMedGoogle Scholar
- Hall WA, Martinez AJ, Dummer JS, Lunsford LD: Nocardial brain abscess: diagnostic and therapeutic use of stereotactic aspiration. Surg Neurol. 1987, 28 (2): 114-118. 10.1016/0090-3019(87)90083-8.View ArticlePubMedGoogle Scholar
- Herkes GK, Fryer J, Rushworth R, Pritchard R, Wilson RM, Joffe R: Cerebral nocardiosis--clinical and pathological findings in three patients. Aust N Z J Med. 1989, 19 (5): 475-478.View ArticlePubMedGoogle Scholar
- Weisburg WG, Barns SM, Pelletier DA, Lane DJ: 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol. 1991, 173 (2): 697-703.PubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/9/194/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.